Chiesi USA, Inc.: Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA,
Read the official notice at FDA (drug) →
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Chiesi USA, Inc.
- Product
- Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01
- Reason / hazard
- Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
- Classification
- Class III
- Status
- Ongoing
- Distribution / sold at
- MO, TN
- Recall initiated
- 2026-08-19
- Code info
- Lot#: 1221973, Exp 3/24/2027
- Product quantity
- 3,002 vials
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Cary
- State
- NC
- Country
- United States
- Event id
- 99705
Free daily digest + "My products" watchlist